Cargando…

The impact of COVID-19 on psychoactive products consumers

INTRODUCTION: The emergence of COVID-19 changed the lifestyle of individuals through the appearance of lockdown. This period seems to have potential effect on some health determinants related to behaviors such as drug addiction. OBJECTIVES: Compare the prevalence and behavior of drug consumers befor...

Descripción completa

Detalles Bibliográficos
Autores principales: Bouighoulidne, S. Ait, Elgot, A., Laamiri, F.Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471002/
http://dx.doi.org/10.1192/j.eurpsy.2021.818
_version_ 1784788967863877632
author Bouighoulidne, S. Ait
Elgot, A.
Laamiri, F.Z.
author_facet Bouighoulidne, S. Ait
Elgot, A.
Laamiri, F.Z.
author_sort Bouighoulidne, S. Ait
collection PubMed
description INTRODUCTION: The emergence of COVID-19 changed the lifestyle of individuals through the appearance of lockdown. This period seems to have potential effect on some health determinants related to behaviors such as drug addiction. OBJECTIVES: Compare the prevalence and behavior of drug consumers before and during the lockdown. METHODS: A cross-sectional study was carried out on 1001 Moroccan addict between April and July 2020, using two international questionnaires: The global drug survey “Special Edition on COVID-19” and the survey on impact of COVID-19 on patients and families. RESULTS: before lockdown, tobacco use (80.2%), alcohol (70.9%), cannabis (46.3%). During lockdown: tobacco consumption remains unchanged (80.7%), alcohol and cannabis consumption reduced significantly, respectively (39.6%) and (40.8%). Results show also the weaning of hallucinogens and solvents. 76.3% decreased their use, the raisons behind these changes were: 39.8% worried about health issues, 26.6% have less opportunities to consume, 23.7% think that the current life style make it difficult to use, 23.4% think they have less ability to obtain drugs. CONCLUSIONS: The lockdown seems to be an opportunity for addicts to reduce drugs consumption. However, setting up support services with targeted interventions is the best chance to decrease psychological stress and avoid the consequences of this reduction.
format Online
Article
Text
id pubmed-9471002
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-94710022022-09-29 The impact of COVID-19 on psychoactive products consumers Bouighoulidne, S. Ait Elgot, A. Laamiri, F.Z. Eur Psychiatry Abstract INTRODUCTION: The emergence of COVID-19 changed the lifestyle of individuals through the appearance of lockdown. This period seems to have potential effect on some health determinants related to behaviors such as drug addiction. OBJECTIVES: Compare the prevalence and behavior of drug consumers before and during the lockdown. METHODS: A cross-sectional study was carried out on 1001 Moroccan addict between April and July 2020, using two international questionnaires: The global drug survey “Special Edition on COVID-19” and the survey on impact of COVID-19 on patients and families. RESULTS: before lockdown, tobacco use (80.2%), alcohol (70.9%), cannabis (46.3%). During lockdown: tobacco consumption remains unchanged (80.7%), alcohol and cannabis consumption reduced significantly, respectively (39.6%) and (40.8%). Results show also the weaning of hallucinogens and solvents. 76.3% decreased their use, the raisons behind these changes were: 39.8% worried about health issues, 26.6% have less opportunities to consume, 23.7% think that the current life style make it difficult to use, 23.4% think they have less ability to obtain drugs. CONCLUSIONS: The lockdown seems to be an opportunity for addicts to reduce drugs consumption. However, setting up support services with targeted interventions is the best chance to decrease psychological stress and avoid the consequences of this reduction. Cambridge University Press 2021-08-13 /pmc/articles/PMC9471002/ http://dx.doi.org/10.1192/j.eurpsy.2021.818 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Bouighoulidne, S. Ait
Elgot, A.
Laamiri, F.Z.
The impact of COVID-19 on psychoactive products consumers
title The impact of COVID-19 on psychoactive products consumers
title_full The impact of COVID-19 on psychoactive products consumers
title_fullStr The impact of COVID-19 on psychoactive products consumers
title_full_unstemmed The impact of COVID-19 on psychoactive products consumers
title_short The impact of COVID-19 on psychoactive products consumers
title_sort impact of covid-19 on psychoactive products consumers
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471002/
http://dx.doi.org/10.1192/j.eurpsy.2021.818
work_keys_str_mv AT bouighoulidnesait theimpactofcovid19onpsychoactiveproductsconsumers
AT elgota theimpactofcovid19onpsychoactiveproductsconsumers
AT laamirifz theimpactofcovid19onpsychoactiveproductsconsumers
AT bouighoulidnesait impactofcovid19onpsychoactiveproductsconsumers
AT elgota impactofcovid19onpsychoactiveproductsconsumers
AT laamirifz impactofcovid19onpsychoactiveproductsconsumers